Ransomware victim disclosure
← All victimscytomx.com
Claimed by Dispossessor · listed 2 years ago
Status timeline
- ListedApr 19, 2024
- Data leakeddate unknown
At a glance
- Group
- Dispossessor
- Status
- Data leaked
- Country
- United States
- Sector
- Healthcare
- Listed on leak site
- Apr 19, 2024
About the victim
AI dossier — public-source company profileCytomX Therapeutics is a clinical-stage biopharmaceutical company focused on developing Probody therapeutics for cancer treatment. The company specializes in antibody-drug conjugates (ADCs) and has multiple programs in clinical trials, with a lead candidate targeting colon cancer. CytomX is publicly traded and operates as an innovative oncology-focused drug developer.
- Industry
- Biopharmaceutical & Oncology
Attack summary
Severity: medium — Confirmed data publication by ransomware group targeting a publicly traded biopharmaceutical company likely holding sensitive R&D, financial, and operational data. However, no specific proof files, data inventory, or operational impact details are provided in the leak post excerpt.The ransomware group Dispossessor claims to have breached CytomX.com and published data. No specific details about the scope of exfiltration, encryption, or data types are stated in the available leak post excerpt.
What the group claims
cytomx.com
Sources
- Victim sitecytomx.com
- Leak posthttps://dispossessor.com/blogs/130
Source
Indexed 2 years agoThis page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.
Is this your supplier? Your competitor? You?
Pro plans monitor your domain, corporate emails, and crypto wallets across every new ransomware leak-site post, breach dump and Telegram callout — alerts within 5 minutes.

